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Human Papillomavirus and Cervical Cancer
Sarah J. Colón, BSN, RN
Otterbein University, Westerville, OH
Introduction
Human papillomavirus (HPV) and
cervical cancer are related issues that
are important topics to discuss.
According to the American Cancer
Society (ACS) (2018) it is estimated
that in 2018 “about 13,240 new cases
of invasive cervical cancer will be
diagnosed.”
The National Cervical Cancer
Coalition (NCCC) reports that cervical
cancer “can almost always be prevented
through regular screening and, if
needed, treatment of abnormal cell
changes” (2018). Human
papillomavirus (HPV) is the virus that
is linked to “abnormal cell changes on
the cervix” (NCCC, 2018).

Why is this topic
important?
•

•

Future interest in women’s health
practice or public health would
address the topic of cervical
cancer and HPV.
Nurse practitioners and other
healthcare providers need to be
aware of the up to date
information to accurately screen
and treat patients.

Underlying
Pathophysiology
Caused by a virus?
According to the NCCC (2018) HPV
“is the name of a group of viruses that
infect the skin. There are more than 100
different types of HPV. Some types of
genital HPV may cause genital warts,
while other types of genital HPV are
linked to abnormal cell changes on the
cervix (detected through Pap tests) that
can lead to cervical cancer. However,
this cancer can almost always be
prevented through regular screening
and, if needed, treatment of abnormal
cell changes.”
“Epidemiological and molecular
evidence indicates that high-risk HPV,
especially HPV type 16 and type 18,
plays a causative role in cervical cancer”
(He, Mao, Hua, Lv, Chen, Angeletti, Dong,
Remmenga, Rodabaugh, Zhou, Lambert,
Yang, Davis, & Wan, 2015, p. 1439).

Underlying Pathophysiology
According to the NCCC (2018),
“Cervical cancer is the first
cancer in women to be identified
as being caused almost
exclusively by a virus.”
•
HPV is detected in 99.7% of
patients with cervical cancer.
(He et al., 2015)
•
HPV is linked to other cancers
including oropharyngeal, oral,
and some head and neck cancers
(NCCC, 2018).
•
Regular pap tests can be
supplemented with additional
HPV testing to optimize the
prevention and treatment for
cervical cancer (NCCC, 2018).
According to the ACS (2016), HPV
is the main cause of cervical cancer
and a common virus that is passed
from one person to another during
sex. Most sexually active people will
have HPV at some point, but few
women Squamous intraepithelial
lesions (SILs) These abnormalities
are divided into two categories:
•
“In low-grade SIL (LSIL) the cells
look mildly abnormal” (ACS,
2016)
•
“In high-grade SIL (HSIL) the
cells look severely abnormal and
are less likely than the cells in
LSIL to go away without
treatment. They are also more
likely to eventually develop into
cancer if they are not treated”
(ACS, 2016)
•

“Cervical cancer was one of the first
human cancers to illustrate the now
generally accepted concept that there is a
step-wise progression from normal cells,
to dysplastic cells, and finally to invasive
disease. Cervical intraepithelial neoplasia
(CIN) refers to pre-invasive dysplasia of
cervical epithelial cells. It is the antecedent
of malignant disease. CIN is categorized
primarily according to the extent to which
squamous cells fail to mature as they
migrate from the basal zone next to the
basement membrane to the surface of
epithelium” (Garrison, Fischer, Karam,
Leary & Pieters, 2015, p. 3).
The ACS reports (2016), “Pre-cancerous
changes in a biopsy are called cervical
intraepithelial neoplasia (CIN). Sometimes
the term dysplasia is used instead of CIN.
CIN is graded on a scale of 1 to 3 based on
how much of the cervical tissue looks
abnormal when viewed under the
microscope.”

Significance of Pathophysiology
Recognizing the underlying pathophysiology is important for staging cervical cancer.
“The treatment of cervical cancer is stage-speciﬁc. While early stage disease can be cured
with radiotherapy or surgery, the most effective treatment for locally advanced stage
patients is concurrent chemotherapy and pelvic irradiation.” (Ordikhani, Arslan,
Marcelo, Sahin, Grigsby, Schwarz & Azab, 2016, p. 1)
There are vaccinations that have been used to prevent HPV. As Camara (2014)
explores the need for vaccines several facts are presented, “HPV is so common that one
in every two sexually-active people will contract at least one HPV infection at some point
during their lifetime. With over one-hundred identified strains, most infections present
either minimal or no risk to health in “immunologically-competent” individuals. HPV
infections are typically “asymptomatic and harmless; most people never know they are
infected, and most infections typically resolve on their own” (p. 39). Information and
statistical findings can be researched and reported to patients in order for them to make
educated decisions to determine if vaccinations should be used.
Researching the appropriate treatment for cervical cancer according to the level of
cell changes that are reflected by the CIN is important.“Pelvic floor disorders are widely
encountered in women who survive gynecological cancers, and an increasing body of
evidence shows that these problems are present at baseline, before initiation of cancer
therapy. Because the primary focus in therapy is cancer eradication, pelvic floor
disorders are frequently overlooked by both patients and specialists, although they have
a major impact on patients’ quality of life. Future research should focus on improving
quality of life in cancer survivors using treatments that cause less damage to the pelvic
floor compartment” (Bodean, Marcu, Spinu, Socea, Diaconu, Munteanu, Taus, and
Cirstoiu, 2018).

How are biopsy
results reported?
The ACS (2016) also explains how the CIN
results are reported,
•
“In CIN1, not much of the tissue looks
abnormal, and it is considered the
least serious cervical pre-cancer
(mild dysplasia).
•
In CIN2 more of the tissue looks
abnormal (moderate dysplasia)
•
In CIN3 most of the tissue looks
abnormal; CIN3 is the most serious
pre-cancer (severe dysplasia) and
includes carcinoma in situ).”
Image 2: The Natural History of HPV infection. As retrieved
http://www.cuhk.edu.hk/sphpc/hpvselfsampling/en/cc-n-hpv.html

Signs and Symptoms

Image 1: HPV from common virus to cervical cancer. As retrieved
http://www.picstopin.com/195/cervical-cancer-—-uvahealth/https:%7C%7Cuvahealth*com%7CPlone%7Cebsco_images%7C2434*jpg/

According to the CDC (2015), “Early on, cervical cancer may not cause signs and
symptoms. Advanced cervical cancer may cause bleeding or discharge from the vagina
that is not normal for you, such as bleeding after sex. If you have any of these signs, see
your doctor. They may be caused by something other than cancer, but the only way to
know is to see your doctor.”
Cervical cancer most commonly takes 10 years to 20 years or more to develop;
women who are no longer sexually active should still have Pap tests.” (NCCC, 2018)
According to the NCCC (2018), Abnormal bleeding includes the following
“Bleeding between regular menstrual periods
Bleeding after sexual intercourse
Bleeding after douching
Bleeding after a pelvic exam
Bleeding after menopause.”
Other symptoms include, “Pelvic pain not related to your menstrual cycle, heavy or
unusual discharge that may be watery, thick, and possibly have a foul odor, increased
urinary frequency, pain during urination” (NCCC, 2018).
It is important to educate patients, even if they are not sexually active anymore
because HPV can remain dormant for many years (NCCC, 2018).

Pathophysiologic
Treatment
Additional outside testing can be
completed to determine the best course of
action when deciding when and how to treat
the different stages of CIN and cervical
cancer. “There is limited data to support or
refute whether review of outside pathology
for diagnostic confirmation is necessary or
cost effective especially for CIN…This is
especially important in younger populations
that desire fertility...treatment for CIN was
not associated with increased risk of total
preterm delivery or spontaneous preterm
delivery but did reveal an increased risk of
preterm premature rupture of membranes...
clinically relevant as CIN II is often the
threshold for treatment and may present as
a transient process especially in younger
women. “(Williams, Agner & Stockdale,
2018, p.4).

Implications of
Nursing Care
Information can be provided to patients
to prevent and screen for cervical cancer.
Risk factors can be presented to encourage
patients to be tested for cervical cancer.
Education through nursing care is
important to support patients.
According to the Centers for Disease
Control and Prevention (CDC) (2016)
There are many types of HPV and it usually
will go away on its own. If it does not, it
may cause cervical cancer over time.
There are other factors that can increase
your risk of cervical cancer:
• Smoking.
• Having HIV (human immunodeficiency
virus) another virus that can make it hard
for someone to fight off other infections
and other immunosuppressive diseases
• Using birth control pills for over five
years.
• Given birth to three or more children.
(ACS, 2016)
Nursing care includes providing
information for patients to learn about
diagnosed diseases.
“Education is a pivotal factor in
promoting HPV preventative behaviors.
Education for the general public about
HPV, the many cancers predominantly
caused by HPV infections, and
characteristics of the vaccine is
fundamental to increasing vaccination
rates and dispelling myths about its safety
and effectiveness. Research analyzing what
methods are most effective for promoting
HPV vaccines in women can be utilized to
encourage receiving the vaccine” (Russell,
2016).

Conclusion
“The introduction of cervical
screening with cytology has significantly
reduced morbidity and mortality related
to cervical cancer in developed nations.
This is due to the detection of both
preinvasive changes as well as invasive
cancer at earlier stages which allows for
earlier treatment. When abnormal
cytology and histology is identified,
patients may be referred to another
facility for further evaluation and
management” (Williams et al., 2018, p.
4).
By examining the pathophysiology,
practitioners can assist patients with
prevention and treatment of HPV and
cervical cancer.
“Cervical cancer is the second most
commonly diagnosed cancer and fourth
leading cause of cancer death in women
worldwide” (He et al., 2015, p. 1426).
Prevention is the key to stopping the
progression of HPV into cervical cancer.
Patients and practitioners alike can
educate themselves to prevent the
progression of this cancer in women.
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